Mylan Laboratories Inc.
1500 Corporate Drive
Suite 400
Canonsburg
Pennsylvania
15317
United States
Tel: 724-514-1800
Website: http://www.mylan.com/
168 articles about Mylan Laboratories Inc.
-
3 Biotech Gems to Stock Up on This Month
2/12/2018
A look at a few bargains in today's choppy market. -
Teva Pharmaceutical Industries Limited Announces Favorable Court Ruling in AZILECT® Patent Infringement Litigation Against Mylan Laboratories Inc.
9/23/2013
-
Mylan Laboratories Inc. Launches Generic Version of Revatio® Tablets
11/13/2012
-
Mylan Laboratories Inc.'s Combination Drug Gets Tentative FDA Approval Under PEPFAR
2/23/2012
-
Matrix Laboratories Limited Completes Name Change to Mylan Laboratories Inc.
10/19/2011
-
Mylan Laboratories Inc. Receives Approval for Generic Version of Effexor XR(R) Capsules
6/2/2011
-
Mylan Laboratories Inc. Receives Approval for Nabumetone Tablets
7/14/2010
-
Mylan Laboratories Inc. Declares Quarterly Preferred Stock Dividend
8/1/2008
-
Mylan Laboratories Inc. Confirms Patent Challenge Relating to Azor(R)
6/4/2008
-
Mylan Inc. Acquires Central Eastern European Generics Businesses of Merck KGaA
6/2/2008
-
Mylan Laboratories Inc. Reports Adjusted Diluted EPS of $0.09 for the Quarter Ended March 31, 2008
5/9/2008
-
Mylan Laboratories Inc. Announces Final FDA Approval for Ropinirole Hydrochloride Tablets
5/7/2008
-
Mylan Laboratories Inc. Schedules Financial Results Conference Call and Live Webcast for the First Quarter Fiscal 2008 Company to Provide Financial Guidance for Fiscal 2008 through 2010
5/1/2008
-
Mylan Laboratories Inc. Appoints Michael J. Monroe Senior Vice President for Global Public Affairs
4/30/2008
-
Mylan Laboratories Inc. Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter
2/28/2008
-
Forest Laboratories, Inc. Announces Amendment to Bystolic(TM) (nebivolol) Agreement
2/28/2008
-
Mylan Laboratories Inc. Announces Appointment of Patrick Vink as Senior Vice President in New Position of Global Head of Biologics
2/26/2008
-
Mylan Laboratories Inc. Announces Appointment of Eric M. Leeds as Senior Vice President and Head of Global Investor Relations
2/25/2008
-
Mylan Laboratories Inc. Revises Timing of Its Financial Results Conference Call for the Quarter and Nine Months Ended Dec. 31, 2007, to 5 p.m. ET
2/21/2008
-
Mylan Laboratories Inc. Confirms Its Matrix Design Fentanyl Patch Is Not Included In the Widespread Recall Announced February 12th
2/14/2008